Skip to main content
. 2019 Jun 20;8(4):235–240. doi: 10.4103/eus.eus_16_19

Table 2.

Inclusion and exclusion criteria

Inclusion criteria Exclusion criteria
Age 18–90-year-old men or women Signed informed consent for CH-EUS, EH-EUS, and FNA
The diagnosis of pancreatic cancer histologically confirmed by FNA/clinical follow-up
Unresectable, locally advanced, and/or metastatic disease
Both pancreatic adenocarcinomas and pancreatic neuroendocrine tumors were included
Previous
chemotherapy or radiotherapy
Resectable
pancreatic tumors

CH-EUS: Contrast-enhanced EUS